Oncorus Inc. (ONCR:NASDAQ) soared at $1.65, representing a gain of 48.6%. On Mon, Jun 06, 2022, ONCR:NASDAQ hit a New 2-Week Intraday Low of $1.06. The stock appeared on our News Catalysts scanner on Wed, Jun 01, 2022 at 07:34 AM in the 'MISCELLANEOUS' category. From Tue, May 24, 2022, the stock recorded 62.50% Up Days and 33.33% Green Days
The share price of the company has been moving sideways in recent weeks.
About Oncorus Inc. (ONCR:NASDAQ)
Oncorus Inc is a clinical stage biopharmaceutical company focused on developing viral immunotherapies to transform outcomes for cancer patients.
Top 10 Gainers:
- AeroClean Technologies Inc. (AERC:NASDAQ), 154.74%
- Applied UV Inc. (AUVI:NASDAQ), 96.4%
- Kiromic BioPharma Inc. (KRBP:NASDAQ), 74.25%
- JanOne Inc. (JAN:NASDAQ), 62.8%
- Accelerate Diagnostics, Inc. (AXDX:NASDAQ), 61.84%
- Oncorus Inc. (ONCR:NASDAQ), 48.65%
- Energy Focus, Inc. (EFOI:NASDAQ), 46.15%
- Houston American Energy Corp. (HUSA:NYSEMKT), 44.67%
- Akouos Inc. (AKUS:NASDAQ), 37.94%
- Omega Therapeutics Inc. (OMGA:NASDAQ), 37.67%